Dongkook Pharmaceutical
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
DongKook Pharmaceutical makes medicines and health-care products supplied to patients and healthcare providers in South Korea.
The company is listed on KOSDAQ, South Korea's technology and small-cap stock exchange. Because the filing excerpt provided covers only a table of contents rather than detailed business descriptions, only a general characterisation of its pharmaceutical operations can be confirmed.
Summary is AI-generated and may contain errors · figures from DART filings
Dongkook Pharmaceutical in five facts
What does Dongkook Pharmaceutical do?
DongKook Pharmaceutical makes medicines and health-care products supplied to patients and healthcare providers in South Korea.
Where is Dongkook Pharmaceutical listed and in which sector?
Dongkook Pharmaceutical (Korean name: 동국제약) trades under KRX code 086450 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Health Care sector, Pharmaceuticals.
How large is Dongkook Pharmaceutical?
Its market capitalisation was US$841.5M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were Dongkook Pharmaceutical's latest annual revenue and operating profit?
For fiscal year 2025, Dongkook Pharmaceutical reported revenue of US$699.6M, operating profit of US$72.9M and net income of US$55.8M, per its annual report on DART (data retrieved from DART on 2026-09-17). Revenue was up 14.1% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-09-17
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.